2007
DOI: 10.1016/j.ejphar.2007.05.005
|View full text |Cite
|
Sign up to set email alerts
|

β-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-α expression in adipocytes

Abstract: Recently, the insulin-sensitizing adipokine adiponectin and the insulin resistance-inducing adipokine tumor necrosis factor- (TNF-) were reported to inhibit each other's production in adipocytes. We investigated the effects of two  3-adrenoceptor agonists, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL-316,243) and (±)-(R*,R*)-[4-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid (BRL37344), on the gene expression of adiponectin, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

4
36
1
2

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(43 citation statements)
references
References 43 publications
4
36
1
2
Order By: Relevance
“…In addition, a negative correlation between p-NE and insulin sensitivity (measured as QUICKI) was found in the present study. This is consistent with results of previous studies, one of which found that catecholamines stimulate adipocyte secretion of tumor necrosis factor-α (TNF-α) (Fu et al, 2007). By directly inhibiting the actions of insulin, TNF-α may contribute to the pathogenesis of catecholamine induced decreased insulin sensitivity (Borst, 2004).…”
Section: Discussionsupporting
confidence: 82%
“…In addition, a negative correlation between p-NE and insulin sensitivity (measured as QUICKI) was found in the present study. This is consistent with results of previous studies, one of which found that catecholamines stimulate adipocyte secretion of tumor necrosis factor-α (TNF-α) (Fu et al, 2007). By directly inhibiting the actions of insulin, TNF-α may contribute to the pathogenesis of catecholamine induced decreased insulin sensitivity (Borst, 2004).…”
Section: Discussionsupporting
confidence: 82%
“…In a previous study, we observed that -adrenergic agonists enhance adiponectin receptor 2 mRNA expression in mice and the 3T3-L1 cell line 6) . Pheochromocytoma is a catecholamine-producing tumor, and the incidence of impaired glucose tolerance in patients with pheochromocytoma has been reported to range from 25% to 75% 7,8) .…”
Section: Introductionmentioning
confidence: 86%
“…Much experimental evidence has demonstrated that adipose tissue is innervated by the sympathetic nervous system in rodents, which can regulate lipolysis, fat cell number, proliferation, and the secretion of some adipocytokines, such as TNF-␣ and MCP-1 (3,19,26). Furthermore, the activity of the sympathetic nervous system has been shown to be increased in obese individuals and proposed to contribute to insulin resistance through the various effects of catecholamines on adipocytes (38).…”
Section: Discussionmentioning
confidence: 99%
“…To examine the relationship between adipocytokines and poststroke hyperglycemia, we used a rat model with ischemic brain injury and examined the changes of several adipose tissue-derived cytokines, including TNF-␣, IL-1␤, IL-6, MCP-1, leptin, and adiponectin, after acute stroke. In addition, sympathetic tone has been shown to be activated by experimental cerebral ischemia (10,34), and several studies have reported that sympathetic nervous system regulates the expression of several adipocytokines through adipocyte ␤-adrenergic receptors (3,19,26). Therefore, this study also determined whether alterations in adipose proinflammatory cytokines following acute stroke, if any, were medicated by sympathetic system using a nonselective ␤-adrenergic receptor blocker, propranolol.…”
mentioning
confidence: 99%